Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Patent CN103910657A reveals metal bromide catalysis for aziridine ring opening, offering cost reduction and high regioselectivity for supply chain stability.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN105658627B enables selective monoarylation for OLED intermediates. Discover cost reduction in electronic chemical manufacturing and high-purity supply solutions.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN116375611A details an efficient photocatalytic method for difluorination. Enhance metabolic stability in drug candidates with our scalable intermediates.
Patent CN113789527B reveals a metal-free electrochemical route for aromatic amines, offering green synthesis and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN109320434A reveals ionic iron catalysts for benzylamine synthesis offering green chemistry advantages and supply chain reliability for pharmaceutical intermediates manufacturing.
Metal-free oxidative ring-opening method for high-purity pharmaceutical intermediates with reduced costs and simplified supply chain management for global buyers.
Novel catalyst-free N-methylation using formic acid and triethylamine in DMSO. High yields, broad substrate scope, suitable for industrial scale-up of fine chemicals.
Novel one-pot method using metabisulfite and peroxides offers cost-effective, scalable production of key pharmaceutical intermediates with high purity.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel Pt/C-catalyzed method enables scalable production of high-purity pharmaceutical intermediates with simplified purification and substantial cost reduction potential.
Patent CN114195726B enables cost reduction in pharmaceutical intermediates manufacturing through simplified CuCl-catalyzed triazolyl arylamine synthesis with enhanced supply chain reliability and scalable production capabilities.
Patent CN114195726B enables high-purity triazolyl arylamine production without anhydrous conditions, reducing manufacturing costs and ensuring reliable supply chain continuity for pharmaceutical intermediates.
Patent CN103804268B enables room-temperature enamine synthesis with high regioselectivity, reducing manufacturing costs and lead times for pharmaceutical intermediates through simplified catalysis.
Discover a scalable, high-yield method for trifluoromethyl aromatic amines with 60-90% yield. Reduce production costs and ensure supply chain stability for your pharmaceutical intermediates.
Solve imidazo[1,2-a]pyridine amine synthesis challenges with 90%+ yields. Reduce steps, costs, and supply chain risks. Contact for CDMO solutions.